血液期刊推荐:CLIN APPL THROMB-HEM 润色咨询

Clinical and Applied Thrombosis/Hemostasis

出版年份:1995 年文章数:107 投稿命中率:60.0%

出版周期:Bimonthly 自引率:5.2% 审稿周期:平均1.57月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均1.57月 (网友贡献,非官方数据)
投稿命中率
60.0% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量20.56% (2018年为10.87%)
自引率
5.2 %
年文章数
107
期刊官网
点击查看 (点击次数:5704)
点击查看 (点击次数:2072次)
作者需知
点击查看 (点击次数:137次)
期刊简介
稿件收录要求

Every issue of Clinical and Applied Thrombosis/Hemostasis (CATH) addresses the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. CATH offers comprehensive coverage of the topics that matter most to your work, including clinical trials, studies on etiology, pathophysiology, diagnosis and treatment of thrombohemorrhagic disorders, assessment of new clinical diagnostic procedures, pharmacological agents, laboratory diagnostic procedures, and patient management plans. CATH continually evaluates new research in areas including essential drugs such as Warfarin, Heparin, low-molecular-weight Heparin, and other emerging drug therapies; the clinical impact on treatment of diseases and conditions such as diabetes, hypertension, pregnancy, hemophilia, and HIV-AIDS; factor defects; platelet disorders; fibrinolytic disorders; DNA/RNA research; and ethnic and population differences in thrombohemorrhagic disorders.

打开APP